Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Color Consistency Testing in MDIs

Posted on By

SOP for Color Consistency Testing in MDIs

Color Consistency Testing Procedures in MDIs

1) Purpose

The purpose of this SOP is to establish procedures for testing the color consistency of metered-dose inhalers (MDIs) to ensure uniform appearance and product quality.

2) Scope

This SOP applies to all personnel involved in color consistency testing activities within the MDI production facility, including quality control technicians, production supervisors, and packaging operators.

3) Responsibilities

The responsibilities for this SOP include conducting color consistency testing, interpreting test results, documenting findings, and ensuring compliance with specifications. Specific roles include:
Quality Control Technicians: Perform color measurements using standardized equipment and procedures.
Production Supervisors: Monitor color consistency during manufacturing and packaging operations.
Packaging Operators: Verify color quality during packaging and labeling processes.

See also  SOP for Maintaining Sterility in MDI Production

4) Procedure

4.1 Sample Preparation
4.1.1 Select representative MDI samples from production batches for testing.
4.1.2 Ensure samples are handled under controlled lighting conditions to minimize color variation.
4.2 Color Measurement
4.2.1 Use spectrophotometers or colorimeters to measure color parameters (e.g., L*a*b* values).
4.2.2 Conduct measurements at multiple points on each MDI unit to assess color uniformity.
4.3 Acceptance Criteria
4.3.1 Compare color measurements against

established color standards and acceptance criteria.
4.3.2 Evaluate deviations and assess impact on product appearance and quality.
4.4 Documentation
4.4.1 Record color consistency testing procedures, including equipment used and measurement locations.
4.4.2 Document test results, deviations observed, and any corrective actions taken.

See also  SOP for Batch Reconciliation in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure

6) Documents, if any

Color consistency testing protocols, test records, color standard references, and batch release certificates should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for color consistency testing requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Pharmacovigilance Safety Database Lock Procedures
Next Post: SOP for Document Control and Management

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version